NucleoBio Corp Revenue

Biotechnology Research • San Antonio, Texas, United States • 1-10 Employees

NucleoBio Corp revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding

Key Contact at NucleoBio Corp

Charles Oyesile

Chief Executive Officer

Company overview

Headquarters	3463 Magic Dr, San Antonio, Texas 78229, US
Website	nucleobio.net
NAICS	541714
SIC	809
Keywords	Gene Therapy, Prostate Cancer Diagnostics, Prostate Cancer Therapeutics
Founded	2017
Employees	1-10
Socials

NucleoBio Corp Email Formats

NucleoBio Corp uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@nucleobio.net), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@nucleobio.net	100%

About NucleoBio Corp

We are enduringly committed to providing state-of-the-art prostate screening tests that produce ground-breaking accurate results. We aim to bring a complete method of testing that fills the gaps and diminishes the inconsistencies of PSA and PSA-based tests, saves lives, reduces costs, and brings peace of mind. We want to be known and valued for breaking through the boundaries of men’s health and bringing forth a gold standard in testing for prostate disease.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

NucleoBio Corp has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

NucleoBio Corp has never raised funding before.

Frequently asked questions

NucleoBio Corp is located in San Antonio, Texas, US.

NucleoBio Corp generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

NucleoBio Corp has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

NucleoBio Corp was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

NucleoBio Corp has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at NucleoBio Corp

Charles Oyesile

Chief Executive Officer

4.8

40,000 users